Cetuximab Plus P-HDFL for the First-line Treatment of Advanced Gastric Cancer
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The investigators have initial evidence that the combination of cetuximab and cisplatin-HDFL
may further improve the efficacy of the cisplatin-HDFL combination chemotherapy.
Phase:
Phase 2
Details
Lead Sponsor:
National Taiwan University Hospital
Collaborators:
Chang Gung Memorial Hospital National Health Research Institutes, Taiwan Taipei Veterans General Hospital, Taiwan Tri-Service General Hospital